Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics (FABrC)

This study has been completed.
Sponsor:
Collaborators:
AstraZeneca
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT00612560
First received: February 7, 2008
Last updated: May 7, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
No publications provided by Roswell Park Cancer Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):